Cost of Treating Heart Failure to Double by 2030

Direct and indirect costs of treating heart failure in America could more than double from $31 billion in 2012 to $70 billion in 2030, according to a policy statement from the American Heart Association.

Advertisement

The cost burden will be fueled by the rising incidence of heart disease, due to both an aging population and an increase in the frequency of conditions that contribute to heart failure, including ischemic heart disease, hypertension and diabetes. The total number of people with heart disease could hit 8 million by 2030, a 46 percent increase from 5 million in 2012.

AHA CEO Nancy Brown advocates taking steps now to reverse this trend. “If we treat patients using existing guidelines, improve care transitions, adequately train our healthcare workforce and reduce disparities in the health outcomes of specific populations, we can lessen the burdens of heart failure,” she said in a news release.

More Articles on Cost of Care:

Playing Moneyball in the OR to Reduce Costs
Study: Acute Care for Elders Unit Linked to Lower Readmissions, Cost
Study: Cost Information Reduces Physicians’ Lab Test Orders

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The 2 KPIs that drive readmissions — and how hospitals act on them in real time

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenter: Nik Rao, Dexur

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.